These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 10333086)
1. Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes. Shi AH; Yoshinari M; Wakisaka M; Iwase M; Fujishima M Horm Metab Res; 1999 Apr; 31(4):283-6. PubMed ID: 10333086 [TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylcholine molecular species in low density lipoprotein and high density lipoprotein in alloxan-induced diabetic rats: effect of probucol. Shi A; Yoshinari M; Iino K; Wakisaka M; Iwase M; Fujishima M Exp Clin Endocrinol Diabetes; 1999; 107(6):337-42. PubMed ID: 10543409 [TBL] [Abstract][Full Text] [Related]
3. Probucol reduces lysophosphatidylcholines in low-density lipoprotein. Yoshinari M; Shi AH; Yoshizumi H; Wakisaka M; Iwase M; Fujishima M Eur J Clin Pharmacol; 2000; 55(11-12):787-92. PubMed ID: 10805055 [TBL] [Abstract][Full Text] [Related]
4. Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus. Sonoki K; Iwase M; Sasaki N; Ohdo S; Higuchi S; Matsuyama N; Iida M Diabetes Res Clin Pract; 2009 Nov; 86(2):117-23. PubMed ID: 19748147 [TBL] [Abstract][Full Text] [Related]
5. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy. Habib SS; Aslam M; Naveed AK; Razi MS Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients. González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671 [TBL] [Abstract][Full Text] [Related]
7. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Rizzo M; Berneis K; Altinova AE; Toruner FB; Akturk M; Ayvaz G; Rini GB; Spinas GA; Arslan M Diabet Med; 2008 Dec; 25(12):1406-11. PubMed ID: 19046238 [TBL] [Abstract][Full Text] [Related]
8. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients. Ybarra J; James RW; Makoundou V; Bioletto S; Golay A Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380 [TBL] [Abstract][Full Text] [Related]
9. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients. Yoshida H; Hirowatari Y; Kurosawa H; Tada N Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl. Cromwell WC; Otvos JD Am J Cardiol; 2006 Dec; 98(12):1599-602. PubMed ID: 17145217 [TBL] [Abstract][Full Text] [Related]
11. Association of oxidized low-density lipoprotein and transforming growth factor-beta in type 2 diabetic patients: a cross-sectional study. Nakhjavani M; Esteghamati A; Asgarani F; Khalilzadeh O; Nikzamir A; Safari R Transl Res; 2009 Feb; 153(2):86-90. PubMed ID: 19138653 [TBL] [Abstract][Full Text] [Related]
13. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies. Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958 [TBL] [Abstract][Full Text] [Related]
14. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612 [TBL] [Abstract][Full Text] [Related]
15. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey. Bruckert E; Baccara-Dinet M; Eschwege E Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463 [TBL] [Abstract][Full Text] [Related]
16. Plasma fatty acids and lipoproteins in type 2 diabetic patients. Lapolla A; Sartore G; Della Rovere GR; Romanato G; Zambon S; Marin R; Manzato E; Fedele D Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886 [TBL] [Abstract][Full Text] [Related]
17. Lipoproteins as predictors of ischemic heart disease in non-insulin-dependent diabetic men. Barrett-Connor E; Philippi T; Khaw KT Am J Prev Med; 1987; 3(4):206-10. PubMed ID: 3452358 [TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment. Iwase M; Sonoki K; Sasaki N; Ohdo S; Higuchi S; Hattori H; Iida M Atherosclerosis; 2008 Feb; 196(2):931-6. PubMed ID: 17350631 [TBL] [Abstract][Full Text] [Related]
19. Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor. Sonoki K; Iwase M; Iino K; Ichikawa K; Ohdo S; Higuchi S; Yoshinari M; Iida M Metabolism; 2003 Mar; 52(3):308-14. PubMed ID: 12647268 [TBL] [Abstract][Full Text] [Related]
20. Factors influencing the low density lipoprotein profile in type 2 diabetic patients. James RW; Marini M; Ruiz J; Pometta D Diabet Med; 1995 Jan; 12(1):61-5. PubMed ID: 7712707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]